Another possible mechanism underlying the benefits of GnRHa pretreatment for PCOS is suppression of LH level, E2 level, hyperandrogenic level, and GnRH-HCG axis function with inhibition of endometrial inflammation and enhanced expression of endometrial adhesion molecules [27]. Here, PLOD1 is linked to polycystic ovary syndrome.